南京招聘

Expected Areas of Responsibilities
工作职责

1. Follow each purchase order to get right materials (or service) with right price and quantity within committed delivery
date.
跟踪执行每个订单，确保按承诺的日期，价格和数量收到所要的货物（或服务）
2. Filing business documents properly.
正确归档业务单证
3. Proactively seeks areas for savings and value enhancement.
积极寻求成本降低和增值服务的机会
4. Work with related colleagues to resolve quality issues.
和相关同事一起解决供应商质量问题
5. Perform supply risk mitigation
降低采购风险
5.1 Timely monitor and analyze suppliers in terms of financial status, on-time delivery, quality issues, capacity issueless issues, business discontinuance, production process change, site change, etc. 定期监控和分析有关供应商的财务状况，准时到货率，质量问题，产能问题，环保问题，业务终止，生产工艺改变， 产地搬迁等
5.2 Work with colleagues at Planning and Sourcing to make up and implement supply risk mitigation plan.
会同计划和供应商开发的同事制订和实施降低采购风险的计划
6. Assist to prepare annual budget
协助做每年的预算
7. Assist GP on RFP (Request for Price or Proposal) and other related projects.
协助GP的同事全球招标及其它相关的项目
8. Provide professional services to stakeholders (external vendors, internal colleagues, etc.)
提供专业的服务给相关方（外部供应商及内部的同事等）？
9. Complete other assignments given by superior
完成领导其他交办任务

Experiences Desired
相关工作经验要求

1.5 years or above relevant purchasing experience in Multi-national companies within pharmaceutical industry preferred
在医药行业内的跨国公司有五年以上相关采购工作经验为佳
2.Familiar with GMP
熟悉GMP
3.Experience of project management in developing project plans, and managing a project through completion to successful implementation
有从制订到成功实施的项目管理经验
4. Bachelor degree or above, major in International Business Management is a plus
本科学历或以上，国际商务管理的专业将优先考虑
5. Have an excellent ability to listen, speak, read and write in both English and Chinese
具有良好的中英文听说读写能力
6. Ability to use office software
具备使用办公自动化软件的能力
7. Ability to prioritize & solve problems independently
具备区分优先次序和独立解决问题的能力
8. Ability to effectively communicate with respective stakeholders and provide a high level of customer service
具备和相关方有效沟通及提供优质服务的能力

百时美施贵宝是一家以“研发并提供创新药物，帮助患者战胜严重疾病”为使命的全球性生物制药公司。

2019年11月20日，百时美施贵宝成功完成了对新基的收购，将双方在领先的科学、创新的药物和优秀的人才等方面的优势合二为一，打造全球领先的生物制药企业。公司在肿瘤、血液、免疫和心血管疾病等领域处于世界前列，并具有丰富的，且具有行业前景的产品管线。

如今，中国已是百时美施贵宝公司全球重要的研发、生产、营销和创新中心之一。我们致力于满足中国未被满足的迫切的重大疾病需求，引领行业发展，开展多元合作，以帮助中国患者战胜严重疾病。